MYBPC3 non-truncating variants in HCM cohorts


The table below lists the 338 rare (MAF<0.0001 in ExAC) non-truncating MYBPC3 variants identified in a cohort of 3267 HCM patients. When this rare variant frequency of 0.10346 is compared with a background population rate of 0.01884, there is a statistically significant case excess of 0.08462 (p<0.0001), which suggests that approximately 277 of these variants may be pathogenic.


Variant Type:      All protein-altering variants     -     Truncating variants     -     Non-Truncating variants
Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (3267)OMGL class ExAC frequency
1. c.1504C>T p.R502Wmissense 59Pathogenic0.000024
2. c.772G>A p.E258Kmissense 47Pathogenic0.000039
3. c.1624G>C p.E542Qmissense 24Pathogenic0.000024
4. c.655G>C p.V219Lmissense 18Likely Pathogenic0.000000
5. c.2429G>A p.R810Hmissense 11VUS0.000033
6. c.3613C>T p.R1205Wmissense 10Likely Pathogenic0.000016
7. c.1483C>G p.R495Gmissense 10Likely Pathogenic0.000000
8. c.3771C>A p.N1257Kmissense 9Likely Pathogenic0.000000
9. c.3065G>C p.R1022Pmissense 5Likely Pathogenic0.000025
10. c.2459G>A p.R820Qmissense 5VUS0.000016
11. c.2308G>A p.D770Nmissense 5Likely Pathogenic0.000008
12. c.442G>A p.G148Rmissense 4Likely Pathogenic0.000042
13. c.1484G>A p.R495Qmissense 4Likely Pathogenic0.000008
14. c.3798C>G p.C1266Wmissense 4VUS0.000000
15. c.2210C>T p.T737Mmissense 3VUS0.000050
16. c.1720C>T p.R574Wmissense 3VUS0.000054
17. c.3277G>T p.G1093Cmissense 3VUS0.000020
18. c.3763G>A p.A1255Tmissense 3VUS0.000075
19. c.1123G>A p.V375Mmissense 3VUS0.000009
20. c.710A>C p.Y237Smissense 3Likely Pathogenic0.000000
21. c.2432A>G p.K811Rmissense 2VUS0.000000
22. c.1828G>A p.D610Nmissense 2VUS0.000000
23. c.2219G>C p.G740Amissense 2VUS0.000000
24. c.3005G>A p.R1002Qmissense 2VUS0.000046
25. c.557C>T p.P186Lmissense 2VUS0.000047
26. c.3751T>C p.Y1251Hmissense 2VUS0.000000
27. c.3470C>T p.P1157Lmissense 2VUS0.000093
28. c.2300A>G p.K767Rmissense 2VUS0.000016
29. c.3582_3593delGGGCTACACTGC inframe 2Likely Pathogenic0.000000
30. c.818G>A p.R273Hmissense 2VUS0.000042
31. c.2573G>A p.S858Nmissense 2Likely Pathogenic0.000000
32. c.1505G>A p.R502Qmissense 2Pathogenic0.000000
33. c.1886T>C p.L629Pmissense 2VUS0.000000
34. c.1483C>T p.R495Wmissense 2Likely Pathogenic0.000000
35. c.3752A>G p.Y1251Cmissense 2VUS0.000000
36. c.3455_3466del p.Ala1152_Lys1155delinframe 2Likely Pathogenic0.000000
37. c.701C>A p.T234Nmissense 1Likely Pathogenic0.000000
38. c.3713T>C p.L1238Pmissense 1Likely Pathogenic0.000000
39. c.3572C>T p.S1191Lmissense 1VUS0.000016
40. c.3316G>A p.D1106Nmissense 1VUS0.000061
41. c.2504G>T p.R835Lmissense 1Likely Pathogenic0.000074
42. c.1433C>T p.S478Lmissense 1Likely Pathogenic0.000017
43. c.1112C>T p.P371Lmissense 1VUS0.000028
44. c.994G>A p.E332Kmissense 1VUS0.000009
45. c.1153G>A p.V385Mmissense 1VUS0.000010
46. c.49C>T p.R17Wmissense 1VUS0.000023
47. c.3728C>G p.P1243Rmissense 1VUS0.000000
48. c.1756C>G p.P586Amissense 1Likely Pathogenic0.000000
49. c.146_148delTCA p.Ile49delinframe 1VUS0.000039
50. c.2968C>G p.P990Amissense 1Likely Pathogenic0.000000
51. c.1097A>C p.Q366Pmissense 1VUS0.000000
52. c.3656T>C p.L1219Pmissense 1VUS0.000000
53. c.2449C>T p.R817Wmissense 1VUS0.000000
54. c.1841A>G p.Y614Cmissense 1VUS0.000000
55. c.2265C>A p.N755Kmissense 1Pathogenic0.000000
56. c.3064C>T p.R1022Cmissense 1VUS0.000008
57. c.1591G>A p.G531Rmissense 1Likely Pathogenic0.000017
58. c.1790G>A p.R597Qmissense 1VUS0.000000
59. c.2030C>T p.P677Lmissense 1VUS0.000000
60. c.1021G>C p.G341Rmissense 1VUS0.000000
61. c.187C>T p.R63Wmissense 1VUS0.000077
62. c.3256T>C p.W1086Rmissense 1VUS0.000000
63. c.631G>A p.D211Nmissense 1VUS0.000009
64. c.1231A>G p.I411Vmissense 1VUS0.000000
65. c.2708G>A p.G903Dmissense 1Likely Pathogenic0.000000
66. c.241G>T p.V81Fmissense 1VUS0.000000
67. c.3364A>T p.T1122Smissense 1Likely Pathogenic0.000000
68. c.2503C>T p.R835Cmissense 1VUS0.000024
69. c.2909G>A p.R970Qmissense 1Likely Pathogenic0.000032
70. c.2198G>A p.R733Hmissense 1VUS0.000034
71. c.1685C>T p.A562Vmissense 1VUS0.000008
72. c.1072G>A p.D358Nmissense 1VUS0.000008
73. c.373G>T p.A125Smissense 1VUS0.000000
74. c.2953A>G p.K985Emissense 1Pathogenic0.000000
75. c.365C>A p.A122Dmissense 1VUS0.000000
76. c.3614G>C p.R1205Pmissense 1Likely Pathogenic0.000000
77. c.1731G>C p.W577Cmissense 1VUS0.000000
78. c.148A>G p.S50Gmissense 1VUS0.000038
79. c.1080G>C p.K360Nmissense 1VUS0.000000
80. c.3614G>A p.R1205Qmissense 1VUS0.000016
81. c.3373G>A p.V1125Mmissense 1VUS0.000022
82. c.1828G>C p.D610Hmissense 1VUS0.000058
83. c.2249C>T p.T750Mmissense 1Likely Pathogenic0.000024
84. c.1456T>G p.W486Gmissense 1VUS0.000000
85. c.1789C>T p.R597Wmissense 1VUS0.000038
86. c.532G>A p.V178Mmissense 1VUS0.000020
87. c.1213A>G p.M405Vmissense 1VUS0.000000
88. c.1021G>A p.G341Smissense 1VUS0.000025
89. c.3206C>A p.P1069Hmissense 1Likely Pathogenic0.000000
90. c.3739G>A p.D1247Nmissense 1VUS0.000000
91. c.1174G>T p.A392Smissense 1VUS0.000000
92. c.2381C>A p.P794Qmissense 1VUS0.000000
93. c.1A>T p.Met1?missense 1Likely Pathogenic0.000000
94. c.3019T>C p.W1007Rmissense 1VUS0.000000
95. c.3452C>T p.A1151Vmissense 1VUS0.000078
96. c.3676C>T p.R1226Cmissense 1VUS0.000058
97. c.2873C>T p.T958Imissense 1VUS0.000065
98. c.2269G>A p.V757Mmissense 1VUS0.000066
99. c.1471G>A p.V491Mmissense 1VUS0.000058
100. c.2197C>T p.R733Cmissense 1Likely Pathogenic0.000085
101. c.1037G>A p.R346Hmissense 1VUS0.000000
102. c.1291G>A p.D431Nmissense 1VUS0.000028
103. c.799C>G p.L267Vmissense 1VUS0.000080
104. c.3334_3351del p.Trp1112_Glu1117delinframe 1Likely Pathogenic0.000000
105. c.844C>T p.R282Wmissense 1Likely Pathogenic0.000000
106. c.188G>A p.R63Qmissense 1VUS0.000039
107. c.2834G>A p.R945Qmissense 1VUS0.000000
108. c.256_258del p.Ser86delinframe 1VUS0.000000
109. c.1455A>T p.K485Nmissense 1VUS0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Alfares AA, Kelly MA, McDermott G, Funke BH, Lebo MS, Baxter SB, Shen J, McLaughlin HM, Clark EH, Babb LJ, Cox SW, DePalma SR, Ho CY, Seidman JG, Seidman CE, Rehm HL. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity. Genet Med. 2015 Nov;17(11):880-8.